Vanguard Group Inc Fate Therapeutics Inc Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 10,404,123 shares of FATE stock, worth $23.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,404,123
Previous 10,569,814 1.57%
Holding current value
$23.1 Million
Previous $34.7 Million 5.04%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$3.12 - $5.57 $516,955 - $922,898
-165,691 Reduced 1.57%
10,404,123 $36.4 Million
Q2 2024

Aug 13, 2024
BUY
$3.26 - $7.08 $2.15 Million - $4.66 Million
658,807 Added 6.65%
10,569,814 $34.7 Million
Q1 2024

May 10, 2024
BUY
$3.54 - $8.35 $2.19 Million - $5.16 Million
617,644 Added 6.65%
9,911,007 $72.7 Million
Q4 2023

Feb 14, 2024
SELL
$1.65 - $3.94 $2.66 Million - $6.36 Million
-1,614,988 Reduced 14.81%
9,293,363 $34.8 Million
Q3 2023

Nov 14, 2023
SELL
$2.02 - $5.04 $1.65 Million - $4.11 Million
-815,023 Reduced 6.95%
10,908,351 $23.1 Million
Q2 2023

Aug 14, 2023
BUY
$4.76 - $6.59 $3.63 Million - $5.02 Million
762,427 Added 6.96%
11,723,374 $55.8 Million
Q1 2023

May 15, 2023
BUY
$4.24 - $11.12 $12.7 Million - $33.2 Million
2,988,396 Added 37.48%
10,960,947 $62.5 Million
Q4 2022

Feb 10, 2023
BUY
$9.86 - $23.83 $1.55 Million - $3.75 Million
157,571 Added 2.02%
7,972,551 $80.4 Million
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $1.2 Million - $2.06 Million
57,040 Added 0.74%
7,814,980 $175 Million
Q2 2022

Aug 12, 2022
BUY
$17.78 - $42.39 $1.19 Million - $2.83 Million
66,768 Added 0.87%
7,757,940 $192 Million
Q1 2022

May 13, 2022
BUY
$29.67 - $60.28 $456,472 - $927,407
15,385 Added 0.2%
7,691,172 $298 Million
Q4 2021

Feb 14, 2022
BUY
$47.84 - $64.34 $2.37 Million - $3.18 Million
49,441 Added 0.65%
7,675,787 $449 Million
Q3 2021

Nov 12, 2021
BUY
$59.27 - $95.73 $3.3 Million - $5.33 Million
55,665 Added 0.74%
7,626,346 $452 Million
Q2 2021

Aug 13, 2021
BUY
$67.25 - $92.52 $509 Million - $700 Million
7,570,681 New
7,570,681 $657 Million

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $215M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email